Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recent progress on Ni-catalysed alkyl-alkyl cross-coupling enabled by asymmetric hydrofunctionalization of alkenes.

Chemical science·2026

Same author

Catalytic Hydrodimerization of Alkenes.

Chemical reviews·2026

Same author

Light-Promoted Copper-Mediated Radical Alkylarylation of Alkenes via Truce-Smiles Rearrangement.

The Journal of organic chemistry·2026

Same author

Discovery and Evaluation of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives as P-gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells.

ChemMedChem·2026

Same author

Exploring Trop-2-Nanobody PPI Interactions through Molecular Dynamics Simulations and Biovalidations.

ACS omega·2026

Same author

Synthesis of α-Dunnione Analogues with Cytotoxicity against HepG2 Cells via Hydrogen Atom Transfer Strategy.

The Journal of organic chemistry·2026

Search research articles

Related Experiment Video

Updated: Sep 18, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Machine Learning Model for Predicting Sertraline-like Activities and Its Impact on Cancer Chemosensitization.

Jin-Yu Xia¹, Ze-Yu Sun², Ying Xue^2,3

¹School of Civil Engineering, College of Chemistry and Environmental Engineering, Sichuan University of Science and Engineering, Zigong 643000, P. R. China.

ACS Chemical Neuroscience

|June 23, 2025

Summary

This summary is machine-generated.

Researchers developed a machine learning model to predict selective serotonin reuptake inhibitor (SSRI) activity. This AI tool accurately identifies novel antidepressant compounds, accelerating drug discovery for depression and anxiety.

Keywords:

SSRI activity prediction drug discovery escitalopram analogs feature engineering machine learning predictive model

More Related Videos

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Related Experiment Videos

Last Updated: Sep 18, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Area of Science:

Computational chemistry
Pharmacology
Artificial intelligence in drug discovery

Background:

Selective serotonin reuptuptake inhibitors (SSRIs) are vital for treating depression and anxiety.
SSRIs show promise as chemosensitizers in cancer therapy.
Identifying novel SSRI compounds is crucial for drug development.

Purpose of the Study:

To develop a machine learning (ML) model for predicting SSRI activity in novel compounds.
To identify compounds with sertraline-like antidepressant effects.
To enhance the efficiency of drug candidate screening.

Main Methods:

Feature engineering applied to chemical structures and bioactivity data of sertraline and analogs.
Training and validation of multiple ML algorithms.
Comparative analysis to select the optimal predictive model, focusing on Support Vector Machine (SVM).

Main Results:

A customized ML model was constructed and validated.
The Support Vector Machine (SVM) model achieved 93% accuracy in predicting SSRI activity.
Optimization of the SVM model resulted in a 95% accuracy rate for predicting more active SSRI compounds.

Conclusions:

A targeted, rapid, and efficient ML model for predicting SSRI activity was successfully developed.
The model is a valuable tool for rapidly screening novel SSRI drug candidates.
This approach significantly contributes to accelerating drug development in psychopharmacology.